Works about PULMONARY fibrosis treatment

Results: 301

Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.

Published in:

Liver International, 2017, v. 37, n. 1, p. 62, doi. 10.1111/liv.13193

By:

Martini, Silvia;
Sacco, Marco;
Strona, Silvia;
Arese, Daniele;
Tandoi, Francesco;
Dell Olio, Dominic;
Stradella, Davide;
Cocchis, Donatella;
Mirabella, Stefano;
Rizza, Giorgia;
Magistroni, Paola;
Moschini, Pamela;
Ottobrelli, Antonio;
Amoroso, Antonio;
Rizzetto, Mario;
Salizzoni, Mauro;
Saracco, Giorgio M.;
Romagnoli, Renato

Publication type:

Article

The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide.

Published in:

2014

By:

Devoe, Craig;
Li, Jian;
Demopoulos, Alexis

Publication type:

Letter

Anti-fibrotic nintedanib—a new opportunity for systemic sclerosis patients?

Published in:

2018

By:

Duarte, Ana Catarina;
Santos, Maria José;
Cordeiro, Ana

Publication type:

Case Study

A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma.

Published in:

Clinical Rheumatology, 2011, v. 30, n. 2, p. 223, doi. 10.1007/s10067-010-1493-4

By:

Domiciano, Diogo;
Bonfá, Eloisa;
Borges, Claudia;
Kairalla, Ronaldo;
Capelozzi, Vera;
Parra, Edwin;
Christmann, Romy

Publication type:

Article

The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.

Published in:

Surgery Today, 2018, v. 48, n. 2, p. 229, doi. 10.1007/s00595-017-1577-8

By:

Takenaka, Tomoyoshi;
Furuya, Kiyomi;
Yamazaki, Koji;
Miura, Naoko;
Tsutsui, Kana;
Takeo, Sadanori

Publication type:

Article

Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.

Published in:

Modern Rheumatology, 2021, v. 31, n. 1, p. 13, doi. 10.1080/14397595.2020.1826665

By:

Shigeki Makino

Publication type:

Article

Autoantibodies against interferon-γ reduce the frequency of pulmonary fibrosis and concentration of C-reactive protein in patients with primary Sjögren's syndrome.

Published in:

Modern Rheumatology, 2015, v. 25, n. 2, p. 325, doi. 10.3109/14397595.2014.934418

By:

Yang, Lin;
Bai, Li;
Wei, Feifei;
Pang, Chunyan;
Wang, Xin;
Wang, Yongfu;
Liu, Xiangyuan

Publication type:

Article

Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.

Published in:

Modern Rheumatology, 2012, v. 22, n. 4, p. 598, doi. 10.3109/s10165-011-0545-1

By:

Takahashi, Takehiro;
Asano, Yoshihide;
Amiya, Eisuke;
Hatano, Masaru;
Tamaki, Zenshiro;
Ozeki, Atsuko;
Watanabe, Aya;
Kawarasaki, Shuichi;
Nakao, Tomoko;
Taniguchi, Takashi;
Ichimura, Yohei;
Toyama, Tetsuo;
Watanabe, Masafumi;
Hirata, Yasunobu;
Nagai, Ryozo;
Sato, Shinichi

Publication type:

Article

Nigella sativa attenuates bleomycin-induced pulmonary fibrosis in rats by inhibition of inflammation, fibrosis, and inducible nitric oxide synthase.

Published in:

Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2015, v. 32, n. 3, p. 121, doi. 10.5835/jecm.omu.32.03.005

By:

Erboga, Mustafa;
Erboga, Zeynep Fidanol;
Donmez, Yeliz Bozdemir;
Aktas, Cevat;
Kanter, Mehmet

Publication type:

Article

A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00628

By:

Yunping Bai;
Jiansheng Li;
Peng Zhao;
Ya Li;
Meng Li;
Suxiang Feng;
Yanqin Qin;
Yange Tian;
Tiqiang Zhou

Publication type:

Article

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00904

By:

Xiao-Ming Zhou;
Gui-Liang Wang;
Xiao-Bo Wang;
Li Liu;
Qin Zhang;
Yan Yin;
Qiu-Yue Wang;
Jian Kang;
Gang Hou

Publication type:

Article

Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.

Published in:

Lung (0341-2040), 2017, v. 195, n. 5, p. 537, doi. 10.1007/s00408-017-0028-z

By:

Galli, Jonathan;
Panetta, Nicholas;
Gaeckle, Nathaniel;
Martinez, Fernando;
Moore, Bethany;
Moore, Thomas;
Courey, Anthony;
Flaherty, Kevin;
Criner, Gerard

Publication type:

Article

Treating CTDs Related Fibrotic ILDs by Immunosuppressants: 'Facts and Faults'.

Published in:

2014

By:

Papiris, Spyros;
Kagouridis, Konstantinos;
Papadaki, Georgia;
Kolilekas, Likurgos;
Manali, Effrosyni

Publication type:

Editorial

Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.

Published in:

Rheumatology, 2019, v. 58, n. 1, p. 165, doi. 10.1093/rheumatology/key223

By:

Landi, Claudia;
Bargagli, Elena;
Carleo, Alfonso;
Refini, Rosa Metella;
Bennett, David;
Bianchi, Laura;
Cillis, Giuseppe;
Prasse, Antje;
Bini, Luca;
Rottoli, Paola

Publication type:

Article

Panniculitis as the initial manifestation of dermatomyositis with anti- MDA5 antibody.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 5, p. 551, doi. 10.1111/ced.13128

By:

Hasegawa, A.;
Shimomura, Y.;
Kibune, N.;
Koshio, J.;
Umemori, Y.;
Abe, R.

Publication type:

Article

Rhus verniciflua Stokes attenuates cholestatic liver cirrhosis-induced interstitial fibrosis via Smad3 down-regulation and Smad7 up-regulation.

Published in:

Anatomy & Cell Biology, 2016, v. 49, n. 3, p. 189, doi. 10.5115/acb.2016.49.3.189

By:

Mi Na Gil;
Du Ri Choi;
Kwang Sik Yu;
Ji Heun Jeong;
Dong-Ho Bak;
Do-Kyung Kim;
Nam-Seob Lee;
Je-Hun Lee;
Young-Gil Jeong;
Chun Soo Na;
Dae Seung Na;
Ki-Hyun Ryu;
Seung Yun Han

Publication type:

Article

Concurrent T cell leukaemia and equine multinodular pulmonary fibrosis in a Hanoverian Warmblood mare.

Published in:

Equine Veterinary Education, 2012, v. 24, n. 4, p. 187, doi. 10.1111/j.2042-3292.2011.00257.x

By:

Schwarz, B.;
Gruber, A.;
Benetka, V.;
Rütgen, B.;
Schwendenwein, I.;
Leidinger, E.;
van den Hoven, R.

Publication type:

Article

Effects of the tumor suppressor PTEN on the pathogenesis of idiopathic pulmonary fibrosis in Chinese patients.

Published in:

Molecular Medicine Reports, 2016, v. 13, n. 3, p. 2715, doi. 10.3892/mmr.2016.4852

By:

BAOSONG XIE;
GUANYING ZHENG;
HONGRU LI;
XIUJUAN YAO;
RUJUN HONG;
RUIHUI LI;
WENXIANG YUE;
YUSHENG CHEN

Publication type:

Article

Suppressor of cytokine signaling 1-modulated metalloproteinases and tissue inhibitor of metalloproteinase in pulmonary fibrosis.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 3, p. 3855, doi. 10.3892/mmr.2015.3810

By:

QIURUI ZHANG;
YI GUO;
RAN DONG;
RANRAN DAI;
MIN ZHOU

Publication type:

Article

Future Therapies in PAH: Update on the New Landscape and Drugs in the Pipeline.

Published in:

Advances in Pulmonary Hypertension, 2014, v. 13, n. 2, p. 76, doi. 10.21693/1933-088x-13.2.76

By:

Preston, Ioana R.

Publication type:

Article

Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats.

Published in:

Inflammation, 2015, v. 38, n. 3, p. 1166, doi. 10.1007/s10753-014-0081-1

By:

Kilic, Talat;
Parlakpinar, Hakan;
Taslidere, Elif;
Yildiz, Sedat;
Polat, Alaadin;
Vardi, Nigar;
Colak, Cemil;
Ermis, Hilal

Publication type:

Article

Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats.

Published in:

Inflammation, 2012, v. 35, n. 5, p. 1732, doi. 10.1007/s10753-012-9491-0

By:

Akgedik, Recep;
Akgedik, Şükran;
Karamanlı, Harun;
Uysal, Sema;
Bozkurt, Bülent;
Ozol, Duygu;
Armutcu, Ferah;
Yıldırım, Zeki

Publication type:

Article

Prolidase Could Act as a Diagnosis and Treatment Mediator in Lung Fibrosis.

Published in:

Inflammation, 2012, v. 35, n. 5, p. 1747, doi. 10.1007/s10753-012-9493-y

By:

Türkbeyler, Ibrahim;
Demir, Tuncer;
Pehlivan, Yavuz;
Kaplan, Davut;
Ceribasi, Ali;
Orkmez, Mustafa;
Aksoy, Nurten;
Taysi, Seyithan;
Kisacik, Bunyamin;
Onat, Ahmet

Publication type:

Article

Pulmonary fibrosis in connective tissue disease (CTD): urgent challenges and opportunities.

Published in:

2017

By:

Fischer, Aryeh;
Donnelly, Seamas C.

Publication type:

Editorial

Anti-MDA5 dermatomyositis and progressive interstitial pneumonia.

Published in:

QJM: An International Journal of Medicine, 2016, v. 109, n. 1, p. 49, doi. 10.1093/qjmed/hcv068

By:

Silveira, M. G.;
Selva-O'Callaghan, A.;
Ramos-Terrades, N.;
Arredondo-Agudelo, K. V.;
Labrador-Horrillo, M.;
Bravo-Masgoret, C.

Publication type:

Article

Reflux in idiopathic pulmonary fibrosis.

Published in:

QJM: An International Journal of Medicine, 2016, v. 109, n. 1, p. 7, doi. 10.1093/qjmed/hcv148

By:

Minnis, P.;
Henry, K.;
Keane, M. P.

Publication type:

Article

Elements: in this month's issue.

Published in:

QJM: An International Journal of Medicine, 2012, v. 105, n. 10, p. 927, doi. 10.1093/qjmed/hcs182

By:

Bannon, Michael

Publication type:

Article

Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.

Published in:

Clinical Science, 2017, v. 131, n. 16, p. 2125, doi. 10.1042/CS20170134

By:

Feng Liu;
Li Wang;
Hualin Qi;
Jun Wang;
Yi Wang;
Wei Jiang;
Liuqing Xu;
Na Liu;
Shougang Zhuang

Publication type:

Article

Kindlin-2 Acts as a Key Mediator of Lung Fibroblast Activation and Pulmonary Fibrosis Progression.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2021, v. 65, n. 1, p. 54, doi. 10.1165/rcmb.2020-0320OC

By:

Ping Zhang;
Jiaxin Wang;
Weiren Luo;
Jifan Yuan;
Chunhong Cui;
Ling Guo;
Chuanyue Wu

Publication type:

Article

The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2021, v. 64, n. 2, p. 163, doi. 10.1165/rcmb.2020-0373PS

By:

Pardo, Annie;
Selman, Moisés

Publication type:

Article

Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2020, v. 62, n. 4, p. 440, doi. 10.1165/rcmb.2018-0293OC

By:

Chaoqun Huang;
Yurong Liang;
Xiangming Zeng;
Xiaoyun Yang;
Dao Xu;
Xuxu Gou;
Sathiaseelan, Roshini;
Senavirathna, Lakmini Kumari;
Pengcheng Wang;
Lin Liu

Publication type:

Article

Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2020, v. 62, n. 4, p. 413, doi. 10.1165/rcmb.2019-0328TR

By:

Ruwanpura, Saleela M.;
Thomas, Belinda J.;
Bardin, Philip G.

Publication type:

Article

Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2020, v. 62, n. 4, p. 479, doi. 10.1165/rcmb.2019-0296OC

By:

Santos, Daniela M.;
Pantano, Lorena;
Pronzati, Gina;
Grasberger, Paula;
Probst, Clemens K.;
Black, Katharine E.;
Spinney, Jillian J.;
Hariri, Lida P.;
Nichols, Royale;
Lin, Yufei;
Bieler, Michael;
Seither, Peter;
Nicklin, Paul;
Wyatt, David;
Tager, Andrew M.;
Medoff, Benjamin D.

Publication type:

Article

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis.

Published in:

2017

By:

Graney, Bridget A.;
Wamboldt, Frederick S.;
Baird, Susan;
Churney, Tara;
Fier, Kaitlin;
Korn, Marjorie;
McCormick, Mark;
Vierzba, Thomas;
Swigris, Jeffrey J.

Publication type:

journal article

Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.

Published in:

2017

By:

De Weerdt, Annick;
Dendooven, Amélie;
Snoeckx, Annemie;
Jan Pen;
Lammens, Martin;
Jorens, Philippe G.;
Pen, Jan

Publication type:

journal article

Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 3, p. 811, doi. 10.1007/s00520-012-1584-7

By:

Yavas, Guler;
Yavas, Cagdas;
Acar, Hilal;
Toy, Hatice;
Yuce, Deniz;
Ata, Ozlem

Publication type:

Article

Modulation of CD11c+ lung dendritic cells in respect to TGF-β in experimental pulmonary fibrosis.

Published in:

Cell Biology International, 2017, v. 41, n. 9, p. 991, doi. 10.1002/cbin.10800

By:

Chakraborty, Kaustav;
Chatterjee, Soumya;
Bhattacharyya, Arindam

Publication type:

Article

Effect of leukotriene receptor antagonists on lung fibrosis in rats.

Published in:

Journal of Applied Toxicology, 2011, v. 31, n. 7, p. 678, doi. 10.1002/jat.1625

By:

Shaker, Olfat G.;
Sourour, Doaa A.

Publication type:

Article

Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program.

Published in:

Pulmonary Therapy, 2017, v. 3, n. 2, p. 317, doi. 10.1007/s41030-017-0049-z

By:

Lancaster, Lisa;
Morrison, Lake;
Auais, Alexander;
Ding, Beiying;
Iqbal, Ahmar;
Polman, Boris;
Flaherty, Kevin

Publication type:

Article

Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 4, p. 3070, doi. 10.3892/etm.2018.6550

By:

Shioya, Sachiko;
Masuda, Takeshi;
Senoo, Tadashi;
Horimasu, Yasushi;
Miyamoto, Shintaro;
Nakashima, Taku;
Iwamoto, Hiroshi;
Fujitaka, Kazunori;
Hamada, Hironobu;
Hattori, Noboru

Publication type:

Article

Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 1800, doi. 10.3892/etm.2018.6378

By:

Song, Xiaoxia;
Yu, Wencheng;
Guo, Fang

Publication type:

Article

Gefitinib-induced interstitial pneumonia: A case report and review of the literature.

Published in:

2014

By:

CHANGQIN LUO;
MEILING LV;
YUYAO LI;
PEIJUN LIU;
JIN YANG

Publication type:

Case Study

Function of the transforming growth factor-β1/c-Jun N-terminal kinase signaling pathway in the action of thalidomide on a rat model of pulmonary fibrosis.

Published in:

Experimental & Therapeutic Medicine, 2014, v. 7, n. 3, p. 669, doi. 10.3892/etm.2013.1457

By:

XUEJUN LIU;
LI QIAN;
HAOYU NAN;
MIAO CUI;
XIAOYAN HAO;
YYFENG DU

Publication type:

Article

Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.

Published in:

Experimental & Therapeutic Medicine, 2013, v. 6, n. 5, p. 1096, doi. 10.3892/etm.2013.1308

By:

SHOBU WATANABE;
NORIHISA NITTA;
AKINAGA SONODA;
AYUMI NITTA-SEKO;
SHINICHI OHTA;
KEIKO TSUCHIYA;
HIDEJI OTANI;
YUKITOMOZAWA;
YUKIHIRO NAGATANI;
KENICHI MUKAISHO;
MASASHI TAKAHASHI;
KIYOSHI MURATA

Publication type:

Article

Idiopathic Pulmonary Fibrosis: The dawn of a new era.

Published in:

2014

By:

Bouros, Demosthenes

Publication type:

Editorial

Pirfenidone photosensitivity rash in a patient with idiopathic pulmonary fibrosis.

Published in:

Pneumon, 2013, v. 26, n. 1, p. 94

By:

Koulelidis, Andreas;
Zacharis, Georgios;
Dolios, Paschalis;
Tzouvelekis, Argyris;
Bouros, Demosthenes

Publication type:

Article

Review article: the reversibility of cirrhosis.

Published in:

Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 9, p. 824, doi. 10.1111/apt.12044

By:

Sohrabpour, A. A.;
Mohamadnejad, M.;
Malekzadeh, R.

Publication type:

Article

Bone morphogenetic protein 7 attenuates epithelial–mesenchymal transition induced by silica.

Published in:

Human & Experimental Toxicology, 2016, v. 35, n. 1, p. 69, doi. 10.1177/0960327115577550

By:

Yang, G.;
Zhu, Z.;
Wang, Y.;
Gao, A.;
Niu, P.;
Chen, L.;
Tian, L.

Publication type:

Article

Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis.

Published in:

Hippokratia, 2013, v. 17, n. 3, p. 228

By:

Benderli Cihan, Y.;
Deniz, K.;
Mutlu, H.;
Kaplan, B.

Publication type:

Article

Functional expression of system x<sub>c</sub><sup>−</sup> is upregulated by asbestos but not crystalline silica in murine macrophages.

Published in:

Inhalation Toxicology, 2012, v. 24, n. 8, p. 476, doi. 10.3109/08958378.2012.689782

By:

Pfau, Jean C.;
Seib, Todd;
Overocker, Jason J.;
Roe, Jeremy;
Ferro, Aaron S.

Publication type:

Article